Abstract:Under normal physiological conditions, the lung remains an oxygen rich environment. However, prominent regions of hypoxia are a common feature of infected and inflamed tissues and many chronic inflammatory respiratory diseases are associated with mucosal and systemic hypoxia. The airway epithelium represents a key interface with the external environment and is the first line of defense against potentially harmful agents including respiratory pathogens. The protective arsenal of the airway epithelium is provided in the form of physical barriers, and the production of an array of antimicrobial host defense molecules, proinflammatory cytokines and chemokines, in response to activation by receptors. Dysregulation of the airway epithelial innate immune response is associated with a compromised immunity and chronic inflammation of the lung. An increasing body of evidence indicates a distinct role for hypoxia in the dysfunction of the airway epithelium and in the responses of both innate immunity and of respiratory pathogens. Here we review the current evidence around the role of tissue hypoxia in modulating the host-pathogen interaction at the airway epithelium. Furthermore, we highlight the work needed to delineate the role of tissue hypoxia in the pathophysiology of chronic inflammatory lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease in addition to novel respiratory diseases such as COVID-19. Elucidating the molecular mechanisms underlying the epithelial-pathogen interactions in the setting of hypoxia will enable better understanding of persistent infections and complex disease processes in chronic inflammatory lung diseases and may aid the identification of novel therapeutic targets and strategies.

Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives

Cytokine-Ion Channel Interactions in Pulmonary Inflammation

A Razor's Edge: Vascular Responses to Acute Inflammatory Lung Injury/Acute Respiratory Distress Syndrome

The endothelium: gatekeeper to lung ischemia-reperfusion injury

Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation

The role of vasculature and angiogenesis in respiratory diseases

Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine

Neutrophil Infiltration and Function in the Pathogenesis of Inflammatory Airspace Disease

Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives

Blood cells and endothelial barrier function

Endothelin as a Proinflammatory Mediator

The Epithelial-Immune Crosstalk in Pulmonary Fibrosis

Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current Concepts and Future Strategies

Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications

Towards a Biohybrid Lung? Impacted Endothelial Layer Integrity in Inflammatory Conditions

Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries

How Adhesion Molecule Patterns Change While Neutrophils Traffic through the Lung during Inflammation

Lung antimicrobial proteins and peptides: From host defense to therapeutic strategies

Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis

Roles of Macrophages and Endothelial Cells and Their Crosstalk in Acute Lung Injury

Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease